There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
77592.19 Cr.Face value
1.00Book value
618.98Div. yield
0.000P/E ratio
22.25P/B ratio
2.16Debt/Eq.
0.24Market Cap
77592.19 Cr.Face value
1.00Book value
618.98Div. yield
0.00%P/E ratio
22.25P/B ratio
2.16Debt/Eq.
0.24
| Dec 25 | Sep 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 51.82% | 51.82% | 0.00% |
| Promoter Pledge | 17.50% | 17.50% | 0.00% |
Aurobindo Pharma, founded in 1986, is emerged as a knowledge-driven company manufacturing active pharmaceutical ingredients (API) and formulation products. Headquartered in Hyderabad, India, the company is an integrated global pharmaceutical major op Read more 
Aurobindo Pharma operates as a company which develops and produces generic and specialty pharmaceuticals and injectables and APIs while expanding its business into respiratory and nasal products and biosimilars and biologics contract manufacturing services.
The company operates in 151 countries through its manufacturing sites and marketing centers located in India and the USA and Europe and key Growth Markets.
